IO Biotech Inc (IOBT)
1.185
-0.06
(-4.44%)
USD |
NASDAQ |
May 31, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
IO Biotech Enterprise Value: -39.91M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -39.91M |
| May 30, 2024 | -36.29M |
| May 29, 2024 | -36.95M |
| May 28, 2024 | -33.00M |
| May 24, 2024 | -34.31M |
| May 23, 2024 | -31.02M |
| May 22, 2024 | -30.36M |
| May 21, 2024 | -30.03M |
| May 20, 2024 | -27.07M |
| May 17, 2024 | -27.07M |
| May 16, 2024 | -25.75M |
| May 15, 2024 | -23.77M |
| May 14, 2024 | -23.11M |
| May 13, 2024 | -25.09M |
| May 10, 2024 | -23.77M |
| May 09, 2024 | -13.89M |
| May 08, 2024 | -19.16M |
| May 07, 2024 | -16.53M |
| May 06, 2024 | -19.82M |
| May 03, 2024 | -20.48M |
| May 02, 2024 | -17.18M |
| May 01, 2024 | -15.87M |
| April 30, 2024 | -21.80M |
| April 29, 2024 | -19.82M |
| April 26, 2024 | -24.43M |
| Date | Value |
|---|---|
| April 25, 2024 | -22.45M |
| April 24, 2024 | -21.80M |
| April 23, 2024 | -21.14M |
| April 22, 2024 | -23.11M |
| April 19, 2024 | -20.48M |
| April 18, 2024 | -21.14M |
| April 17, 2024 | -19.16M |
| April 16, 2024 | -18.50M |
| April 15, 2024 | -18.50M |
| April 12, 2024 | -15.87M |
| April 11, 2024 | -12.57M |
| April 10, 2024 | -13.89M |
| April 09, 2024 | -11.91M |
| April 08, 2024 | -16.53M |
| April 05, 2024 | -13.89M |
| April 04, 2024 | -9.937M |
| April 03, 2024 | -5.984M |
| April 02, 2024 | -5.326M |
| April 01, 2024 | -5.326M |
| March 28, 2024 | -29.22M |
| March 27, 2024 | -29.22M |
| March 26, 2024 | -32.18M |
| March 25, 2024 | -29.22M |
| March 22, 2024 | -27.90M |
| March 21, 2024 | -36.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-109.83M
Minimum
Oct 27 2023
451.68M
Maximum
Nov 05 2021
-28.15M
Average
-56.50M
Median
Jul 17 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.46M |
| Total Expenses (Quarterly) | 20.20M |
| EPS Diluted (Quarterly) | -0.30 |
| Earnings Yield | -157.6% |